Enzon Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net income was USD 0.32 million compared to USD 0.197 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.112 USD | -13.75% | +26.41% | +19.66% |
1st Jan change | Capi. | |
---|---|---|
+19.66% | 9.64M | |
+10.53% | 115B | |
+12.26% | 106B | |
-4.33% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.32% | 17.56B | |
-40.50% | 17.32B | |
+6.08% | 14.03B | |
+30.96% | 12.13B |
- Stock Market
- Equities
- ENZN Stock
- News Enzon Pharmaceuticals, Inc.
- Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024